<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Botulinum Toxin in Migraine Treatment

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

10.4274/npa.y7198

dc.identifier.other

dc.description.volume

50

dc.description.issue

1

Publisher

TURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGI

DOI

10.4274/npa.y7198

Abstract

Since botulinum toxin might have a therapeutic effect on pain, many studies investigating the efficiency of botulinum toxin in headache treatment have been done. The most satisfying results were achieved by botulinum toxin type A (BoNT/A) in the treatment of chronic migraine. In this paper, we reviewed the clinical effectiveness of BoNT/A in migraine and included our clinical experience. In our ongoing pilot study, where we have repeated BoNT/A injections every 12 weeks, The difference in the Migraine Disability Assessment (MIDAS) scores between the first and the second injections was 61.1\%
and between the first and the 3rd injections was found to be 65.72\%.

Description

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By